European Archives - Page 15 of 1043 - European Medical Journal

Britain

ABPI reveals data on UK’s life sciences competitive edge

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK pharma space.

Antihistamines Offer New Hope in Erythropoietic Protoporphyria

This study revealed an association between elevated hepatic histamine levels, mast cell infiltration, and erythropoietic protoporphyria progression.

New AI Model Detects Early Signs of Parkinson’s with High Accuracy

A deep-learning algorithm predicts Parkinson’s disease using medical claims and prescriptions, improving early detection and clinical screening.

5 minutes with... Jaime Manzanera, Eisai

Jaime Manzanera, EMEA Brand Director, Oncology, Eisai, shares his perspective on maximising ROI in pharmaceutical marketing and more.

AI-Driven Model CAPI-Detect Improves Diagnosis of Systemic Sclerosis

A new machine learning model, CAPI-Detect, has demonstrated over 90% accuracy in diagnosing systemic sclerosis (SSc) using nailfold videocapillaroscopy (NVC).

Food Insecurity in Pregnancy Linked to Higher Risk of Complications

A new study has found that food insecurity during pregnancy is associated with higher risks of gestational diabetes, preeclampsia, preterm birth, and NICU admissions.

CBD Reduces Anxiety in Women With Advanced Breast Cancer

A new study suggests that cannabidiol (CBD) may help reduce anxiety in women with advanced breast cancer undergoing tumour burden assessments.

Twelve New Mpox Vaccination Sites Open Across England

The NHS has expanded its mpox vaccination programme across England, opening 12 new sites to improve access for those at higher risk of infection.

Artificial Intelligence Enhances Kidney Cancer Diagnosis with CT Imaging

A new study demonstrates how artificial intelligence (AI) can improve the diagnosis of renal masses using pre-operative CT scans. The AI models developed outperformed experienced radiologists in distinguishing benign from malignant tumors and predicting cancer aggressiveness, paving the way for more precise kidney cancer treatment.

Frederik-Schjesvold

Hema Now: Episode 10: Shaping the Future of Myeloma

Fredrik Schjesvold, Head of the Oslo Myeloma Center, Oslo University Hospital, and Head of the Norwegian myeloma association joins the show.